Momordica charantia (Bitter Gourd) peel, pulp, seed and whole fruit extract inhibits mouse skin papillomagenesis

Toxicology Letters

Volumn 94, Issue 1, 1998, Pages 37-46

  Singh, Anjali ^a   Singh, Satya Prakash ^a   Bamezai, Ramesh ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Momordica charantia; Skin papillomagenesis

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; GLUTATHIONE TRANSFERASE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FRUIT; MALE; MOUSE; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN PAPILLOMA; TUMOR PROMOTION;

ANIMALS; BIOTRANSFORMATION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; CUCURBITACEAE; LIVER; MALE; MICE; PAPILLOMA; PLANT EXTRACTS; SKIN NEOPLASMS;

ANIMALIA; CUCURBITA; MOMORDICA; MOMORDICA CHARANTIA;

EID: 0032536169     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(97)00099-4     Document Type: Article

References (29)

1. Alberts D.S., Garcia D.J. An overview of clinical cancer chemoprevention studies with emphasis on positive phase III studies. J. Nutr. 125s:1995;692-697.
2. Biswas A.R., Ramaswamy S., Bapna J.S. Analgesic effect of Momordica charantia seed extract in mice and rats. J. Ethnopharmacol. 31:1991;115-118.
3. Blot W.J., Lim J.-Y., Taylor P.R. et al. Nutrition intervention trials in linxian, china : supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population. J. Natl. Cancer Inst. 85:1993;1483-1491.
4. . Boone C.W., Kelloff C.J., Malone W.E. Identification of canditate cancer chemopreventive agents and their evaluation in animal models and human clinical trials. A review. Cancer Res. 50:1990;2-9.
5. Bourinbaiar A.S., Lee-Huang S. Potentiation of anti-HIV activity of anti-inflammatory drugs, dexamethasone and indomethacin, by MAP30, the antiviral agent from bitter melon. Biochem. Biophys. Res. Commun. 208:1995;779-785.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. Ellmann G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:1959;70-77.
8. Guevara A.P., Lim-Sylianco C., Dayrit F., Finch P. Antimutagens from Momordica charantia. Mutat. Res. 230:1990;121-126.
9. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249:1974;7130-7139.
10. Katiyar S.K., Agarwal R., Mukhtar H. Inhibition of tumor promotion in sencar mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res. 56:1996;1023-1030.
11. Kelloff G.J., Boone C.W., Malone W.E., Steele V.E. Chemoprevention clinical trials. Mutat. Res. 267:1992;292-295.
12. Lee-Huang S., Huang P.L., Huang P.L., Bourinbaiar A.S., Chen H.C., Kung H.F. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc. Natl. Acad. Sci. USA. 92:1995;8818-8822.
13. Meister A. Glutathione, ascorbate and cellular protection. Cancer Res. 54s:1994;1969-1975.
14. Morse M.A., Stoner G.D. Cancer chemoprevention : principles and prospects. Carcinogenesis. 14:1993;1737-1746.
15. Ng T.B., Wong C.M., Li W.W., Yeung H.W. Peptides with antilipolytic and lipogenic activities from seeds of the Bitter Gourd Momordica charantia (family cucurbitaceae). Gen. Pharmacol. 18:1987;275-281.
16. Ng T.B., Tam P.P., Hon W.K., Choi H.L., Yeung H.W. Effects of Momorcharins on ovarian response to gonadotropin-induced superovulation in mice. Int. J. Fertil. 33:1988;123-128.
17. Ng T.B., Chan W.Y., Yeung H.W. Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from cucurbitaceae plants. Gen. Pharmacol. 23:1992;579-590.
18. Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem. 239:1964;2370-2378.
19. Porro G., Lento P., Marcucci F., Gromo G., Modena D. Different cytotoxic activity and intracellular fate of an anti-CD5-momordin immunotoxin in normal compared to tumor cells. Cancer Immunol. Immunother. 40:1995;213-218.
20. Rybak S.M., Lin J.J., Newton D.L. et al. In vitro anti-tumor activity of the plant ribosome inactivating proteins MAP30 and GAP31. Int. J. Oncol. 5:1994;88-94.
21. Shabib B.A., Khan L.A., Rahman R. Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats : depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose -1,6-biphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem. J. 292:1993;267-270.
22. Singh A., Rao A.R. Modulatory effect of areca nut on the action of mace (Myristica fragrans, Houtt) on the hepatic detoxification system in mice. Food Chem. Toxicol. 31:1993;517-521.
23. Singh A., Rao A.R. Evalution of the modifying influence of arecanut on the garlic-modulated hepatic detoxication system enzymes, sulhydryl content and lipid peroxidation in mice. Teratog. Carcinog. Mutag. 15:1995;127-134.
24. Singh A., Singh S.P., Bamezai R. Modulatory influence of chlorophyllin on the mouse skin papillomagenesis and xenobiotic detoxication system. Carcinogenesis. 17:1996;1459-1463.
25. 1 pups. Nutr. Cancer. 25:1996;101-110.
26. Slaga T.J. Inhibition of the induction of cancer by antioxidants. Adv. Exp. Med. Biol. 369:1995;167-174.
27. Sparnins V.L., Venegas P.L., Wattenberg L.W. Glutathione S-transferase activity: enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents. J. Natl. Cancer Inst. 68:1982;493-496.
28. Wattenberg L.W. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 52s:1992;2085-2091.
29. Zhu Z.J., Zhong Z.C., Luo Z.Y., Xiao Z.Y. Studies on the active constituents of Momordica charantia L. Yao Hsueh Hsueh Pao. 25:1990;898-903.